Financials
- Fiscal year
- 2024
- Total assets
- €185,736
- Profit
- €7,673
- Solvency
- 97.6%
Total assets▲ 5.9%
Net result
20182024
AMBOPLUS
ActiveSummary
AMBOPLUS has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €181,354 and a net result of €7,673. Equity is growing by ~18.8% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.7% (low).
Overview
What they do
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
1 site
How big
€185,736total assets 2024
- Equity
- €181,354
- Profit
- €7,673
Turnover not published (abridged schema)
Who decides
Accounts 12 d early0 of 2 deeds read
Why 77- Higher-failure-rate sector+ Long track recordLatest accounts filed on timeShow the evidence
Checked score
Score 2024
Axes · tick = 2023
Profitability74▲+4
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13,000 at 30 days acceptable
Liquidity ample (current ratio 39.32 against 94.74 in 2023; short-term debt: 2.4% and cash: 5.1% of total assets), and 2.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-11-2025 was due by 30-06-2026 and was filed on 18-06-2026, 12 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
12 d early
2024
19 d early
2023
13 d early
2022
24 d early
2021
22 d early
2020
9 d early
2019
25 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 18 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-11-2026 and is due by 30-06-2027. Nothing is late today. Usually files around 11 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today30-11-2026 close30-06-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Annual accounts filedfiscal year 2024 · micro…
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Timeline
- Events
- 16
- Since
- 2017
- Next accounts
- by 30-06-2027
- 18-06-2026Annual accounts filed
- 11-06-2025Annual accounts filed
- 17-06-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 16-01-2007
- Year ends
- 30-11
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.